Last reviewed · How we verify
NCT07059052
Illness Perception and Quality of Life in Colorectal Cancer With Ascites
trial in Colorectal Cancer (MSI-H) in 218 participants. Completed in 30 April 2025.
30 April 2025
Quick facts
| Lead sponsor | Hebei Provincial Hospital of Traditional Chinese Medicine |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 218 |
| Start date | 1 January 2024 |
| Primary completion | 30 April 2025 |
| Estimated completion | 30 April 2025 |
| Sites | 1 location across China |
Conditions studied
- Colorectal Cancer (MSI-H) — all drugs for Colorectal Cancer (MSI-H) →
Sponsor
Hebei Provincial Hospital of Traditional Chinese Medicine
Who can join
18 and older, any sex, with Colorectal Cancer (MSI-H). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aimed to investigate the impact of illness perception on the quality of life (QoL) in patients diagnosed with colorectal cancer (CRC) complicated by ascites. The study explores how patients' cognitive and emotional beliefs about their illness relate to their physical, psychological, and social well-being.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07059052
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Colorectal Cancer (MSI-H)
Currently open trials in the same condition.
- NCT07063550 — Microplastics in Paraneoplastic and Intratumoral for Colorectal Cancer · active not recruiting
- NCT07523763 — Neoadjuvant Low-dose Immunotherapy in Locally Advanced MMR-deficient Colorectal Cancer · Phase 2 · active not recruiting
- NCT05086692 — A Beta-only IL-2 ImmunoTherapY Study · Phase 1, PHASE2 · recruiting
Other Hebei Provincial Hospital of Traditional Chinese Medicine trials
Trials by the same sponsor.
- NCT07234682 — Impact of Anxiety-Sleep Symptom Cluster on Immune Function and Quality of Life in Colorectal Cancer · completed
- NCT05539144 — A New Delineation Approach for Oral Cavity, Oropharynx, Larynx and Hypopharynx in IMRT for Head and Neck Cancer · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07059052 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hebei Provincial Hospital of Traditional Chinese Medicine
- Last refreshed: 10 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07059052.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing